Eurolife Healthcare Is Contributing To The Growth Of The IV Infusion Bottle Seals & Caps Market With The Investment Of INR 100 Crores For Expanding Production Of Closed Intravenous Infusion Bottles

 The increasing prevalence of chronic disorders is expanding the global IV infusion bottle seals & caps market size. For instance, according to a report by World Health Organization (WHO), 2017, chronic diseases are the major cause of disabilities, worldwide. Moreover, 73% of deaths in 2020 are expected to be due to chronic diseases. In addition, four of the most prominent chronic diseases include cardiovascular, cancer, pulmonary, and type 2 diabetes. According to the World Health Organization (WHO), around 18.1 million cancer cases and 9.6 million deaths were registered globally in 2018. The increasing cancer burden is due to several factors, including population growth and the geriatric population.

Asia Pacific is expected to dominate the global IV infusion bottle seals & caps market and this is attributed to the increasing investment in the packaging industry key players in the region. For instance, in August 2020, Creador, a Malaysia-based private equity firm invested US$ 34.1 Mn in the Shriji Polymers (India) Ltd., a manufacturer of high-density polyethylene bottles, polypropylene caps, and other specialty products. The investment is expected to expand Shriji’s product offerings and global presence, and Creador gained a minority stake in the Shriji Polymers.

1.      In December 2019, Eurolife Healthcare announced its plant to invest INR 100 crores for expanding its production capacity of closed intravenous infusion bottles. The increased production capacity will enable the manufacture of an additional 40 million of the close system IV bottles monthly

2.      In November 2018, JCR Pharmaceuticals Co., Ltd announces the launch of Agalsidase Beta BS I.V. Infusion 5mg and 35mg [JCR]  For Fabry Disease

3.      In March 2019, UCB Japan Co., Ltd. and Daiichi Sankyo Company, Limited together announce the launch of anti-epilepsy drug VIMPAT® for I.V. infusion 200mg (generic name: lacosamide) has been launched in Japan.

While the medical industry continues to expand on the increase, the market for IV infusions is witnessing tremendous growth not only in developed countries but even in developing nations like India and China. With the rising need for effective IV therapies in such countries, IV bottle reseal products have gained popularity among patients and health practitioners. The use of IV solutions has been reported to reduce morbidity and mortality rates as IV therapies are often applied at the time of emergency

Comments

Post a Comment

Popular posts from this blog

Global Video Event Data Recorder Market Continues To Grow Owing To the Increased Demand from the Automobile Sector and Stringent Road Safety Measures Taken By Governmental Bodies across the World

Image
  Video event data recorder (VEDR) is a device that captures and stores the data from live events such as seminars, meetings, product demonstrations, trade shows, presentations, conventions, training programs, live concerts, and events that use sophisticated optics and light systems to create the video images at a recording-quality level. The devices can record the full duration of any event. VEDRs are integrated with advanced event management solutions that utilize advanced monitoring and reporting features to track, manage and analyze the captured data. Some systems also allow users to upload content directly from their computers or smartphones to multiple different locations and devices. Market Dynamics                                                The latest video event data recorders from leading brands like Canon, Casio, Fuji, Samsung, Olympus, Panasonic, Pentax, Samsung, Voip, Apple, Blackberry, and PIXA are all designed to improve the quality of video capture. The newest p
Read more

Astrum Has Expanded Its Presence In India Infrared Thermometer Market

Image
  The Infrared Thermometer market is witnessing the fastest growth in the Asia Pacific region and this can be accredited to the growing aging population in the region which is driving demand for healthcare services. Japan has the highest growing aging population in the country. According to the Statistics Bureau, Ministry of Internal Affairs and Communications, in 2019, the aged population (65 years old and over) was 35.89 million, constituting 28.4 percent of the total population (i.e., 1 in every 4 persons) and marking a record high in Japan. The rise in prevalence of infectious disease and increase in the demand for the product for newborns as children cannot hold the contact thermometer is playing a key role in the overall development of the infrared thermometer market . According to the World Health Organization, HIV, tuberculosis, malaria, neglected tropical diseases, and viral hepatitis affects billions of people around the world and causes more than 4 million deaths each year
Read more

Increasing Demand for Processed Food and Initiatives to Challenges Assumptions about Monosodium Glutamate to Augment Growth of Monosodium Glutamate Market

Image
  Monosodium Glutamate (MSG) is one of the most widely used food-additives in commercial foods. Market Dynamics Increasing demand for processed food is expected to propel growth of the global monosodium glutamate market. For instance, according to the U.S Department of Agriculture, export of prepared food from U.S. increased from US$ 5, 849 million in 2015 to US$ 6,682 million in 2019. Moreover, increasing sales in the restaurant sector is also expected to aid in growth of the market. For instance, according to The National Restaurant Association, restaurant sales are expected to value US$ 863 billion in 2019 in the U.S., witnessing an increase of 3.6% from 2018. Initiatives to challenges assumptions about monosodium glutamate are expected to offer lucrative growth opportunities for players in the global monosodium glutamate market . For instance, in December 2020, Ajinomoto Co., Inc. announced a new campaign to address the heart of MSG’s perception problem in the U.S. Moreover,
Read more